BEDAQUILINE vs BELANTAMAB MAFODOTIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BEDAQUILINE vs BELANTAMAB MAFODOTIN: Safety Overview
| Metric | BEDAQUILINE | BELANTAMAB MAFODOTIN |
|---|---|---|
| Total FAERS Reports | 3,655 | 2,293 |
| Deaths Reported | 1,137 | 843 |
| Death Rate | 31.1% | 36.8% |
| Hospitalizations | 1,250 | 599 |
| Average Patient Age | 42.2 yrs | 67.3 yrs |
| % Female Patients | 41.1% | 39.2% |
| FDA Approval Date | Dec 28, 2012 | N/A |
| Manufacturer | Janssen Products, LP | GlaxoSmithKline LLC |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |